UnknownNCT02439658
Genetics of QT Prolongation With Antiarrhythmics
Studying Congenital long QT syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Massachusetts General Hospital
- Principal Investigator
- Christopher Newton-Cheh, MD, MPHMassachusetts General Hospital
- Intervention
- Dofetilide and/or sotalol(drug)
- Enrollment
- 1000 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2014 – 2023
Study locations (5)
- University of Colorado Hospital, Aurora, Colorado, United States
- Massachusetts General Hospital, Boston, Massachusetts, United States
- Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
- Mayo Clinic, Rochester, Minnesota, United States
- Cleveland Clinic, Cleveland, Ohio, United States
Collaborators
Mayo Clinic · The Cleveland Clinic · University of Colorado, Denver · National Heart, Lung, and Blood Institute (NHLBI)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02439658 on ClinicalTrials.govOther trials for Congenital long QT syndrome
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT06887387Wearable Devices for Patient Monitoring in Long QT SyndromeQueen Mary University of London
- ENROLLING BY INVITATIONNANCT07233421Frequency of Hypoglycemia in Children With Beta-blocker Treated Long QT-syndromeHelsinki University Central Hospital
- RECRUITINGNANCT04336644Continuous Versus Intermittent cARdiac Electrical moNitorinGWashington University School of Medicine
- RECRUITINGNANCT05348564Comparing Direct vs Indirect Methods for Cascade ScreeningUniversity of Maryland, Baltimore
- RECRUITINGNCT06087367Building of a Diagnostic/Prognostic Database for Human ERG Variant EffectsNantes University Hospital